As Nation Recognizes Laboratory Professionals Week, ACLA Highlights Extraordinary Efforts of “The Laboratory People”
Association announces plans to highlight members’ efforts during Laboratory Professionals Week (April 19 – 25)
WASHINGTON, D.C. — Today, the American Clinical Laboratory Association (ACLA) announced plans to highlight stories of laboratory researchers, technicians, administrative staff, and medical officers who are going above and beyond the call of duty to serve patients during the COVID-19 pandemic.
“Tens of thousands of laboratory staff are working around the clock to deliver accurate, reliable tests results to all who need it,” said Julie Khani, president of ACLA. “As we mark the start of Laboratory Professionals Week today, there’s never been a better time to honor their dedication and service,” Khani said.
Responding to unprecedented demand for testing, ACLA members, including ARUP, BioReference Laboratories, LabCorp, Mayo Clinic Laboratories, Quest Diagnostics, Sonic Healthcare, Exact Sciences and Biodesix have dramatically increased testing capacity over the past several weeks, performing more than 2.45 million tests to date.
As noted at Friday’s White House briefing, ACLA members can serve virtually every area of the United States. “The American Clinical Laboratory Association — this is America’s commercial industrial backbone,” said Admiral Brett Giroir. “They have no backlog of tests, they’ve ramped up their production, so their turnaround time is about 48 hours.”
For today’s behind-the-scenes look at the people working to bring vital testing capacity to the U.S, click here. You can also follow ACLA on LinkedIn and Twitter.
# # #
ACLA is a not-for-profit association representing the nation’s leading clinical and anatomic pathology laboratories, including national, regional, specialty, hospital, ESRD and nursing home laboratories. The clinical laboratory industry employs nearly 295,000 people directly, and generates over 117,000 additional jobs in supplier industries. Clinical laboratories are at the forefront of personalized medicine, driving diagnostic innovation and contributing more than $106 billion to the nation’s economy.
